Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

View source ↗

Summary

Long-term observational study update on Lecigon for advanced Parkinson's disease; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lecigon (levodopa-entacapone intestinal gel)

Snippet

Sponsor: Britannia Pharmaceuticals Ltd. | Conditions: Advanced Parkinson Disease | Status: ACTIVE_NOT_RECRUITING